Canagliflozin Tablets 300 mg are an oral antidiabetic drug belonging to the sodium-glucose cotransporter 2 (SGLT2) inhibitor class.
It works by inhibiting SGLT2 in the kidney, reducing renal glucose reabsorption and increasing urinary glucose excretion, thereby lowering blood glucose levels independently of insulin secretion.
Composition
Each film‑coated tablet contains:
Canagliflozin …… 300 mg
Indications
As monotherapy or in combination with other antidiabetic medicinal products (including insulin), for the treatment of adult patients with type 2 diabetes mellitus to improve glycemic control.
Key Features
Novel insulin‑independent glucose‑lowering mechanism
Once‑daily oral administration, convenient for patients
May also support weight reduction and mild blood pressure reduction
Good gastrointestinal and systemic tolerance
Stable formulation, consistent bioavailability
Strict quality control complying with pharmacopoeia standards
Manufactured under GMP conditions
Complete registration dossiers available for global registration and marketing
Storage
Store in a cool, dry place, protected from light and moisture.
Keep out of reach of children.
